93181-82-9 Usage
Chemical structure
The compound has a complex structure that includes a piperidine ring, a pyridazine ring, and a butanoate group.
Composition
It is composed of a piperidine moiety attached to a butanoate chain.
Substituent
The piperidine includes a pyridazine ring with a 2-chlorophenyl substituent.
Potential applications
The compound may have potential applications in pharmacology and medicinal chemistry due to its unique structure.
Interaction with biological targets
The compound's structure could potentially allow it to interact with biological targets in a specific and selective manner.
Research and investigation
Further research and investigation into the properties and potential uses of 1-(6-(2-Chlorophenyl)-3-pyridazinyl)-4-piperidinyl butanoate could provide valuable insights for drug discovery and development.
Drug discovery and development
The compound's unique structure and potential interactions with biological targets make it a promising candidate for further study in the field of drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 93181-82-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,1,8 and 1 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 93181-82:
(7*9)+(6*3)+(5*1)+(4*8)+(3*1)+(2*8)+(1*2)=139
139 % 10 = 9
So 93181-82-9 is a valid CAS Registry Number.
93181-82-9Relevant articles and documents
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy
Hallot,Brodin,Merlier,Brochard,Chambon,Biziere
, p. 369 - 375 (2007/10/02)
A series of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines derivatives was synthesized and evaluated for anticonvulsant activity. The compounds were screened in mice for their ability to antagonize maximal electroshock- and bicuculline-induced seizures;
Pyridazine and pyrimidine compounds active on the central nervous system as sedatives or anticonvulsants
-
, (2008/06/13)
The present invention relates to the compounds of formula STR1 in which X1 represents N or STR2 X2 represents N or STR3 provided that X1 and X2 are different from each other; R1 and R2 bein
